statement
On October 17, 2026, the National Pharmaceutical Pricing Authority (NPPA) capped the trade margin on 137 non-scheduled anti-cancer medicines, including patented ones, at 30% of the maximum retail price (MRP).
A statement by National Pharmaceutical Pricing Authority (NPPA). Statements are as reported by the cited publishers — not verified by DecisionGateway.
On October 17, 2026, the National Pharmaceutical Pricing Authority (NPPA) capped the trade margin on 137 non-scheduled anti-cancer medicines, including patented ones, at 30% of the maximum retail price (MRP)
Discussion
Related claims
On October 17, 2026, the National Pharmaceutical Pricing Authority (NPPA) capped the trade margin on 137 non-scheduled anti-cancer medicines, including patented ones, at 30% of the maximum retail price (MRP).post author · statementOn 17 October 2026, the National Pharmaceutical Pricing Authority (NPPA) capped the trade margin on 137 anti-cancer non-scheduled medicines, including patented drugs, at 30% of the maximum retail price (MRP).नेशनल फार्मास्युटिकल प्राइसिंग अथॉरिटी (NPPA) · statementOn 17 October 2026, the National Pharmaceutical Pricing Authority (NPPA) capped the trade margin on 137 non-scheduled anti-cancer medicines, including patented drugs, at 30% of the maximum retail price (MRP).post · statementThe National Pharmaceutical Pricing Authority (NPPA) has capped trade margins on the Maximum Retail Price (MRP) of 137 anti-cancer drugs.National Pharmaceutical Pricing Authority · statementThe NPPA acts under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers.National Pharmaceutical Pricing Authority · statementConsumers can check drug prices on the NPPA website and the official 'Pharma Sahi Daam' mobile app.post author · statement